Trade Mark Journal No.2025/049 5 December 2025

UK00004301227 26 November 2025 (5)

CELLDEX

Class 5: Pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of cancer; pharmaceutical preparations for the treatment of mast-cell mediated disorders; pharmaceutical preparations for the treatment of urticaria; pharmaceutical preparations for the treatment of chronic spontaneous urticaria (csu); pharmaceutical preparations for the treatment of chronic inducible urticaria (cindu); pharmaceutical preparations for the treatment of prurigo nodularis (pn); pharmaceutical preparations for the treatment of atopic dermatitis (ad); pharmaceutical preparations for the treatment of cold urticaria (coldu); pharmaceutical preparations for the treatment of symptomatic dermographism (sd); antibodies for medical purposes; therapeutic antibodies for human use for the treatment of inflammatory diseases.

Celldex Therapeutics, Inc.

Representative: Stevens Hewlett & Perkins